Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 21 min ago
Peer-reviewedCC BY-NC-NDInternal Medicine

Refeeding Syndrome Induced by Fursultiamine Infusion in Wernicke Encephalopathy: A Case Report

  • Shotaro Ishikawa
  • Satoshi Ota
  • Natsuko Nakazaki
  • Yoshio Nagai
  • Takashi Ikehara
Read full textPDFDOICite

Abstract

Wernicke encephalopathy is caused by thiamine deficiency, and treatment with high-dose thiamine is recommended for its management. We herein report the case of an older adult woman who developed refeeding syndrome after receiving intravenous fursultiamine. Although the patient's oral food intake was restricted to prevent refeeding syndrome, the total caloric load, including glucose contained in fursultiamine, exceeded the recommended amount. This case demonstrates that the caloric contribution of glucose present in fursultiamine should not be overlooked when treating Wernicke encephalopathy with high-dose parenteral fursultiamine.

Related

  1. Glial Fibrillary Acidic Protein Astrocytopathy Mimicking Wernicke's Encephalopathy
    Keishu Murakami, Shoko Yorozu, Takuma Eimoto +1
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textNeurologyJ-STAGE
  2. Atypical Cerebellar Vermis Signal Abnormality in Wernicke Encephalopathy
    Tanya F. Panwala, Yu Sakai, J. Eric Schmitt +1
    The NeurohospitalistPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Beyond Ophthalmoplegia: Wernicke Encephalopathy with Anisocoria.
    Yoshihiro Ito, Koji Hayashi, Haruka Kurihara +2
    Reports (MDPI)Peer-reviewedCC BYFull textNeurologyEurope PMC
  4. Undertreatment of Wernicke encephalopathy in alcohol-related clinical contexts: a scoping review of diagnosis, thiamine regimens, and clinical management.
    André Akira Sueno Goldani, Gabriel Feitosa, Eduarda Vasconcelos Colchete +5
    Addiction science & clinical practicePeer-reviewedCC BYFull textNeurologyEurope PMCDOAJ
  5. Clinical and radiological features of posterior reversible encephalopathy syndrome in children: a retrospective study
    Hua Huang, Shujuan Jiang, Huan Xu +2
    Frontiers in pediatricsPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{ishikawa2026refeeding,
  title = {{Refeeding Syndrome Induced by Fursultiamine Infusion in Wernicke Encephalopathy: A Case Report}},
  author = {Shotaro Ishikawa and Satoshi Ota and Natsuko Nakazaki and Yoshio Nagai and Takashi Ikehara},
  journal = {Internal Medicine},
  year = {2026},
  month = jul,
  doi = {10.2169/internalmedicine.7285-26},
  url = {https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7285-26/_article},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Refeeding Syndrome Induced by Fursultiamine Infusion in Wernicke Encephalopathy: A Case Report
AU  - Shotaro Ishikawa
AU  - Satoshi Ota
AU  - Natsuko Nakazaki
AU  - Yoshio Nagai
AU  - Takashi Ikehara
PY  - 2026
DA  - 2026/07/18
JO  - Internal Medicine
DO  - 10.2169/internalmedicine.7285-26
UR  - https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7285-26/_article
AB  - Wernicke encephalopathy is caused by thiamine deficiency, and treatment with high-dose thiamine is recommended for its management. We herein report the case of an older adult woman who developed refeeding syndrome after receiving intravenous fursultiamine. Although the patient's oral food intake was restricted to prevent refeeding syndrome, the total caloric load, including glucose contained in fursultiamine, exceeded the recommended amount. This case demonstrates that the caloric contribution of glucose present in fursultiamine should not be overlooked when treating Wernicke encephalopathy with high-dose parenteral fursultiamine.
SN  - 1349-7235
SN  - 0918-2918
ER  -